跳至主要内容
临床试验/NCT03811925
NCT03811925
Unknown
不适用

Local and Systemic Vascular Function Following Drug Coated Balloon vs. Stenting in the Superficial Femoral Artery

University Hospital, Essen1 个研究点 分布在 1 个国家目标入组 30 人2018年6月1日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Peripheral Arterial Disease
发起方
University Hospital, Essen
入组人数
30
试验地点
1
主要终点
local endothelial function
最后更新
7年前

概览

简要总结

Endovascular treatment of the superficial femoral artery has a high initial success rate, but restenosis occurs in up to 60% of cases. While restoration of tissue perfusion is achieved, interventional strategies affect endothelial function. Endothelial dysfunction is the pathophysiologic principle involved in the initiation and progression of arteriosclerosis.

The aim of this study is to determine the impact of endovascular strategies in the superficial femoral artery on local and systemic endothelial and vascular function.

注册库
clinicaltrials.gov
开始日期
2018年6月1日
结束日期
2019年7月1日
最后更新
7年前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

发起方
University Hospital, Essen
责任方
Principal Investigator
主要研究者

Fadi Al-Rashid

Principal Investigator

University Hospital, Essen

入排标准

入选标准

  • Clinical diagnosis of chronic, symptomatic lower limb ischemia as defined by Rutherford 2, 3, 4, or 5
  • Planed peripheral intervention TASC A-C
  • Subject must be between 40 and 85 years old
  • Female of childbearing potential must have a negative pregnancy test within 10 days prior to index procedure and utilize reliable birth control until completion of the 12-month angiographic evaluation
  • Guidewire must cross lesion(s) within the true lumen, without a relevant sub-intimal course
  • Vessel diameter ≥3.0 mm and ≤6.0 mm
  • Willing to comply with the specified follow-up evaluation
  • Written informed consent prior to any study procedures

排除标准

  • Lesions TASC D
  • Angiographic evidence of thrombus within target vessel
  • Thrombolysis within 72 hours prior to the index procedure
  • Aneurysm in the femoral artery or popliteal artery
  • Concomitant hepatic insufficiency, deep venous thrombus, coagulation disorder or receiving immunosuppressant therapy
  • Unstable angina pectoris at the time of the enrollment
  • Recent myocardial infarction or stroke \< 30 days prior to the index procedure
  • Life expectancy less than 12 months
  • Septicemia at the time of enrollment
  • Known or suspected active infection at the time of the index procedure, excluding an infection of a lower extremity wound of the target limb

结局指标

主要结局

local endothelial function

时间窗: 6 months Follow Up

Change of endothelial function, assessed by the change in the vasodilatative reserve of the femoral artery (flow-mediated dilation = FMD)

次要结局

  • Systemic endothelial function(6 months Follow Up)
  • target lesion revascularization(6 months Follow Up)
  • ABI (Ankle Brachial Index)(6 months Follow Up)
  • Primary patency(6 months Follow Up)
  • Vessel stiffness(6 months Follow Up)

研究点 (1)

Loading locations...

相似试验